Press release
Rising Adoption Of Personalized Medicine To Boost The Market Growth: Major Factor in the Transformation of the Tegsedi Market in 2025
Tegsedi Market Size
In recent times, the growth rate (CAGR) of the tegsedi market has been $XX%. The market size which sat at $XX million in 2024 is expected to escalate to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. Various factors have contributed to the growth observed in the historic period, such as the rising prevalence of hereditary transthyretin amyloidosis, an increased demand for targeted therapies, government and regulatory support, an increase in ambulatory care centers, and the growing number of medical professionals.
The market size of tegsedi is projected to observe an $XX (CAGR) rise in the coming years, potentially reaching a substantial $XX million by 2029, with a compound annual growth rate (CAGR) of $XX%. The development anticipated for the forecast period is linked to several influential factors such as the escalating need for oral medications, a rise in the incidence of coexisting conditions, growing awareness surrounding rare genetic dilemmas, increased investment into precision medicine, and a surge in the number of clinical trials. Significant trends expected to occur in the forecast period comprise of technological evolution, individualized medicine, genetic therapies, telemedicine, and combination therapies.
What Key Elements Are Boosting Growth in the Tegsedi Market?
The growth of the Tegsedi market is projected to be fueled by the increasing acceptance of personalized medicine. This method tailors treatments based on the patient's genetic makeup, lifestyle, and environment, aiming for more effective results. Genomic research advancements, improved diagnostic tools, and the burgeoning demand for more precise treatments have all contributed to the growing use of personalized medicine. By adapting treatment to the genetic and clinical characteristics of patients with hereditary transthyretin-mediated amyloidosis, personalized medicine increases Tegsedi's effectiveness and safety, ensures the best therapeutic outcomes, and reduces possible risks. The Personalized Medicine Coalition, a non-profit organization based in the US, stated that the Food and Drug Administration (FDA) permitted 16 new personalized treatments for patients afflicted with rare illnesses in 2023, a significant increase from the six approved in 2022. Therefore, the expanding use of personalized medicine is propelling the Tegsedi market's growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20445&type=smp
Who Are the Major Industry Players Fueling Tegsedi Market Expansion?
Major companies operating in the tegsedi market are Ionis Pharmaceuticals Inc.
Which Key Developments Are Influencing the Tegsedi Market?
The predominant trend observed in the tegsedi market is the shift towards creative drug category pricing policies to increase accessibility, enhance patient compliance, and power market penetration by offsetting cost-effectiveness with medicinal value. Drug category pricing implicates the procedure of assigning costs to drugs, factoring their curative category, effectiveness, market demand, and competitive landscape within a distinct class of pharmaceuticals. For instance, in October 2021, US-based biopharmaceutical firm PTC Therapeutics, Inc. confirmed that Tegsedi (inotersen) had received Category 1 recognition, a breakthrough drug category pricing from Brazil's Câmara de Regulação do Mercado de Medicamentos (CMED), acknowledging its innovative effectiveness over pre-existing therapies. This has also been validated by the Brazilian Health Regulatory Agency (Anvisa), a Brazilian governmental body, for treating Stage 1 or 2 polyneuropathy in adult patients suffering from hereditary transthyretin-mediated amyloidosis (hATTR). Tegsedi emerges as the pioneer antisense medication in Brazil to tackle the underlying cause of the disease. Clinical trials have shown its potential to significantly lower TTR protein levels and uplift the lifestyle of patients.
How Is the Segmentation of the Tegsedi Market Defined?
The tegsedi market covered in this report is segmented -
1) By Indication: Neurological Manifestations; Cardiac Involvement; Other Indications
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Hospitals; Clinics; Ambulatory Care; Home Care
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tegsedi-global-market-report
What Is the Leading Region in the Tegsedi Market?
North America was the largest region in the tegsedi market in 2024. The regions covered in the tegsedi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Tegsedi Global Market Report?
- Market Size Analysis: Analyze the tegsedi Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the tegsedi Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall tegsedi market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the tegsedi market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20445
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Adoption Of Personalized Medicine To Boost The Market Growth: Major Factor in the Transformation of the Tegsedi Market in 2025 here
News-ID: 3875320 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Tegsedi
Hereditary Transthyretin Amyloidosis (hATTR) Market: Investment-Ready Growth Tre …
DelveInsight's "Hereditary Transthyretin Amyloidosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hereditary Transthyretin Amyloidosis, historical and forecasted epidemiology as well as the Hereditary Transthyretin Amyloidosis market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Hereditary Transthyretin Amyloidosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hereditary Transthyretin Amyloidosis…
Hereditary Transthyretin Amyloidosis (hATTR) Market to Witness Promising Upswing …
The Key Hereditary Transthyretin Amyloidosis Companies in the market include - Alnylam Pharmaceuticals, AstraZeneca, Ionis Pharmaceuticals, Intellia Therapeutics, Neurimmune, Alexion Pharmaceuticals, Novo Nordisk, Eidos Therapeutics, Corino Therapeutics, Prothena, Regeneron Pharmaceutical, and others.
DelveInsight's "Hereditary Transthyretin Amyloidosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hereditary Transthyretin Amyloidosis, historical and forecasted epidemiology as well as the Hereditary Transthyretin Amyloidosis market trends in the United States, EU4 (Germany,…
Familial Amyloid Polyneuropathy (FAP) Market to Reach USD 2.4 Billion by 2034
Familial Amyloid Polyneuropathy (FAP) is a progressive, inherited rare disease caused by mutations in the transthyretin (TTR) gene, leading to the buildup of misfolded amyloid proteins in the peripheral nerves and multiple organs. This buildup causes nerve damage, autonomic dysfunction, and multi-system complications that, without treatment, can become life-threatening.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72015
In recent years, FAP has emerged as a critical focus area in the…
Global Tegsedi Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Tegsedi Market Size and Projected Growth Rate?
In recent times, the tegsedi market has experienced a considerable growth of XX (HCAGR). Projected growth indicates a substantial escalation from $XX million in 2024 to $XX million in 2025, indicating a compound annual growth rate (CAGR) of XX%. The historic period's…
Rising Adoption Of Personalized Medicine To Boost The Market Growth: A Key Facto …
Which drivers are expected to have the greatest impact on the over the tegsedi market's growth?
The growing adoption of personalized medicine is expected to propel the Tegsedi market forward. Personalized medicine customizes treatment based on an individual's genetic makeup, lifestyle, and environment for more effective results. The rise in personalized medicine is fueled by advances in genomic research, improved diagnostics, and a demand for targeted treatments. Personalized medicine enhances the…
Creatinine Measurement Market Discovering Untapped Opportunities: Latest Market …
Global "Creatinine Measurement Market" Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
